Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    8527050 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Omalizumab to Treat Hyper-IgE (Job's) Syndrome
Conditions: Hyper-IgE Syndrome;   Job's Syndrome
Intervention: Drug: Omalizumab (Xolair)
2 Completed Omalizumab to Treat Eosinophilic Gastroenteritis
Condition: Gastroenteritis
Intervention: Drug: Omalizumab

Study has passed its completion date and status has not been verified in more than two years.